Literature DB >> 29045376

Drug therapy: On the treatment trail for ALS.

Andrew Scott.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29045376     DOI: 10.1038/550S120a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  10 in total

Review 1.  Neurotheranostics as personalized medicines.

Authors:  Bhavesh D Kevadiya; Brendan M Ottemann; Midhun Ben Thomas; Insiya Mukadam; Saumya Nigam; JoEllyn McMillan; Santhi Gorantla; Tatiana K Bronich; Benson Edagwa; Howard E Gendelman
Journal:  Adv Drug Deliv Rev       Date:  2018-10-26       Impact factor: 15.470

2.  Amide signal intensities may be reduced in the motor cortex and the corticospinal tract of ALS patients.

Authors:  Zhuozhi Dai; Sanjay Kalra; Dennell Mah; Peter Seres; Hongfu Sun; Renhua Wu; Alan H Wilman
Journal:  Eur Radiol       Date:  2020-09-09       Impact factor: 5.315

3.  Impaired Pentose Phosphate Pathway in the Spinal Cord of the hSOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis.

Authors:  Tesfaye Wolde Tefera; Katherine Bartlett; Shirley S Tran; Mark P Hodson; Karin Borges
Journal:  Mol Neurobiol       Date:  2019-01-26       Impact factor: 5.590

4.  A New Quantitative Cell-Based Assay Reveals Unexpected Microtubule Stabilizing Activity of Certain Kinase Inhibitors, Clinically Approved or in the Process of Approval.

Authors:  Sacnicte Ramirez-Rios; Sophie Michallet; Leticia Peris; Caroline Barette; Clotilde Rabat; Yangbo Feng; Marie-Odile Fauvarque; Annie Andrieux; Karin Sadoul; Laurence Lafanechère
Journal:  Front Pharmacol       Date:  2020-04-30       Impact factor: 5.810

5.  Neuroprotective Fragment C of Tetanus Toxin Modulates IL-6 in an ALS Mouse Model.

Authors:  Laura Moreno-Martinez; Miriam de la Torre; María J Muñoz; Pilar Zaragoza; José Aguilera; Ana C Calvo; Rosario Osta
Journal:  Toxins (Basel)       Date:  2020-05-17       Impact factor: 4.546

Review 6.  Neuroimmune Crosstalk Between the Peripheral and the Central Immune System in Amyotrophic Lateral Sclerosis.

Authors:  Weiyi Yu; Ji He; Xiying Cai; Zhou Yu; Zhangyu Zou; Dongsheng Fan
Journal:  Front Aging Neurosci       Date:  2022-05-03       Impact factor: 5.750

Review 7.  The microtubule cytoskeleton: An old validated target for novel therapeutic drugs.

Authors:  Laurence Lafanechère
Journal:  Front Pharmacol       Date:  2022-09-15       Impact factor: 5.988

8.  Isotopic Evidence for Disrupted Copper Metabolism in Amyotrophic Lateral Sclerosis.

Authors:  Lucie Sauzéat; Emilien Bernard; Armand Perret-Liaudet; Isabelle Quadrio; Alain Vighetto; Pierre Krolak-Salmon; Emmanuel Broussolle; Pascal Leblanc; Vincent Balter
Journal:  iScience       Date:  2018-08-01

9.  Intramuscular Injection of Bone Marrow Stem Cells in Amyotrophic Lateral Sclerosis Patients: A Randomized Clinical Trial.

Authors:  Emilio Geijo-Barrientos; Carlos Pastore-Olmedo; Pedro De Mingo; Miguel Blanquer; Joaquín Gómez Espuch; Francisca Iniesta; Natalia García Iniesta; Ana García-Hernández; Carlos Martín-Estefanía; Laura Barrios; José M Moraleda; Salvador Martínez
Journal:  Front Neurosci       Date:  2020-03-24       Impact factor: 4.677

Review 10.  A perspective on therapies for amyotrophic lateral sclerosis: can disease progression be curbed?

Authors:  Xiaojiao Xu; Dingding Shen; Yining Gao; Qinming Zhou; You Ni; Huanyu Meng; Hongqin Shi; Weidong Le; Shengdi Chen; Sheng Chen
Journal:  Transl Neurodegener       Date:  2021-08-10       Impact factor: 8.014

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.